A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
PHASE3CompletedINTERVENTIONAL
Enrollment
151
Participants
Timeline
Start Date
October 31, 1997
Study Completion Date
November 30, 1999
Conditions
Bipolar DisorderManic Disorder
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
NCT00250367 - A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder. | Biotech Hunter | Biotech Hunter